ESR1 and breast carcinoma: Although the paper did not rigorously address whether or not ERK5 promoted the aggressiveness of ERα(−) breast cancer cells through modulating actin dynamics independently of its catalytic activity, estrogen-mediated transcription in ERα(+) breast cancer cells required ERK5 activation by MEK5 [38].